My Cart

Cadherin-17

Cadherin-17 Overview

English NameCadherin-17Approved Drugs0
Drugs in Clinical Trials8Target SynonymLiver-intestine cadherin,HPT-1,Intestinal peptide-associated transporter HPT-1,LI-cadherin,HPT-1 Cadherin,Cadherin 17, LI Cadherin (Liver-Intestine),HPT1,Human Intestinal Peptide-Associated Transporter HPT-1,LI Cadherin,Cadherin,Cadherin 17,Human Peptide Transporter 1
Highest Development StagePhase 2 Clinical
English NameCadherin-17
Target SynonymLiver-intestine cadherin,HPT-1,Intestinal peptide-associated transporter HPT-1,LI-cadherin,HPT-1 Cadherin,Cadherin 17, LI Cadherin (Liver-Intestine),HPT1,Human Intestinal Peptide-Associated Transporter HPT-1,LI Cadherin,Cadherin,Cadherin 17,Human Peptide Transporter 1
Approved Drugs0
Drugs in Clinical Trials8
Highest Development StagePhase 2 Clinical

Cadherin-17 Background

Cadherin-17, also known as liver-intestine (LI) Cadherin, belongs to the cadherin family of calcium-dependent cell adhesion molecules. In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.

Cadherin-17 Synonyms

Cadherin-17,CDH17,HPT-1,LI-cadherin

Antibody Project Trading Platform

Project NameProject StageMolecule TypeMolecule SourceDisease AreaIndication
CDH17 mAb - 01PCCMonoclonalHumanized MouseSolid TumorColorectal cancer,Gastric Cancer

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CHM-2101CDH17-CAR T; CHM-2101; CHM2101; CHM-2101 CAR-T cellsPhase 2 ClinicalUniversity Of PennsylvaniaStomach Neoplasms; Pancreatic Neoplasms; Neuroendocrine Tumors; Colorectal Neoplasms; Gastrointestinal Neoplasms
Details
BI-905711BI-905711Phase 1 ClinicalBoehringer Ingelheim GmbhPancreatic Neoplasms; Cholangiocarcinoma; Gastrointestinal Neoplasms
Details
CabotamigARB-202Phase 1 ClinicalArbele CorpLiver Neoplasms; Biliary Tract Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal adenocarcinoma; Gastrointestinal Neoplasms
Details
Anti-CDH17 CAR-T cells Therapy (Guangzhou Bio-Gene Technology)Phase 1 ClinicalGuangzhou Bio-Gene Technology Co LtdSolid tumours
Details
HS-20110HS20110; HS-20110Phase 1 ClinicalShanghai Hansoh Biomedical Co Ltd, Changzhou Hengbang Pharmaceutical Co LtdSolid tumours
Details
Anti-CDH17 CAR-T Cell therapy (UTC Therapeutics)Phase 1 ClinicalUTC Therapeutics IncSolid tumours
Details
TORL-3-600TORL-3-600Phase 1 ClinicalTorl Biotherapeutics LLCSolid tumours; Colorectal Neoplasms
Details
CDH17 - IHC Test(Arbele)ClinicalArbele CorpGastrointestinal Neoplasms
Details

Product Reviews

  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland